UBS Group
CLBT icon

UBS Group’s Cellebrite CLBT Stock Holding History

UBS Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.31M Sell
500,766
-69,382
-12% -$917K ﹤0.01% 3791
2026
Q1 		$7.86M Buy
570,148
+193,772
+51% +$2.92M ﹤0.01% 3612
2025
Q4 		$6.79M Buy
376,376
+187,220
+99% +$3.36M ﹤0.01% 3711
2025
Q3 		$3.51M Sell
189,156
-239,622
-56% -$3.76M ﹤0.01% 4408
2025
Q2 		$6.86M Sell
428,778
-309,968
-42% -$5.53M ﹤0.01% 3531
2025
Q1 		$14.4M Buy
738,746
+244,570
+49% +$5.15M ﹤0.01% 2667
2024
Q4 		$10.9M Buy
494,176
+128,956
+35% +$2.48M ﹤0.01% 2945
2024
Q3 		$6.15M Buy
365,220
+9,903
+3% +$147K ﹤0.01% 2860
2024
Q2 		$4.25M Buy
355,317
+145,144
+69% +$1.62M ﹤0.01% 3027
2024
Q1 		$2.33M Buy
210,173
+121,945
+138% +$1.24M ﹤0.01% 3788
2023
Q4 		$764K Buy
88,228
+50,401
+133% +$392K ﹤0.01% 4733
2023
Q3 		$289K Buy
37,827
+31,595
+507% +$237K ﹤0.01% 5081
2023
Q2 		$44.9K Buy
6,232
+1,929
+45% +$11.2K ﹤0.01% 6534
2023
Q1 		$26.2K Buy
+4,303
New +$23.3K ﹤0.01% 6885
2022
Q1 		– Sell
-2,865
Closed -$23K – 10311
2021
Q4 		$23K Sell
2,865
-1,885
-40% -$17.8K ﹤0.01% 7671
2021
Q3 		$44K Buy
+4,750
New +$49.6K ﹤0.01% 6435

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

UBS Group's CLBT Position: Q2 2026 in Review

UBS Group reduced its Cellebrite (CLBT) stake by 12% in Q2 2026, selling an estimated $917K and leaving 500,766 shares worth $7.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3791.

UBS Group first reported a position in CLBT in Q3 2021 and has held it in 16 quarters since. The position peaked at $14.4M in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • UBS Group held 500,766 shares of Cellebrite worth $7.31M as of Q2 2026.
  • UBS Group sold 69,382 Cellebrite shares in Q2 2026, an estimated $917K.
  • Cellebrite made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3791 holding.
  • UBS Group first reported a position in Cellebrite in Q3 2021 and has held it in 16 quarters since.
  • UBS Group's Cellebrite position peaked at $14.4M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.